P T Fan|D T Yu|P J Clements|R Bluestone - JoVE Visualize

Showing results (181-190 of 194) with videos related to

Pageof 20

Sort By:

Annals of Internal Medicine|February 1, 1994

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.

Infection and Immunity|September 24, 1998

Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27W P Maksymowych, T Ikawa, A Yamaguchi, et al.

Cancer|December 15, 1983

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.

Arthritis and Rheumatism|November 11, 1999

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.

Journal of Medicinal Chemistry|September 1, 1995

Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activitiesS J Lee, Y Konishi, D T Yu, et al.

Arthritis and Rheumatism|June 12, 1999

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.

Clinical and Experimental Rheumatology|May 1, 1991

Epitope analysis of an HLA-B27-derived synthetic peptide: a possible approach to analyzing HLA class I antigensY P Zhao, B J Shi, H K Deng, et al.

Annals of Internal Medicine|April 15, 1993

Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.

Rheumatology (Oxford, England)|June 27, 2001

Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.

Arthritis and Rheumatism|November 18, 2000

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.

Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:

Pageof 20

Annals of Internal Medicine|February 1, 1994

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.

Infection and Immunity|September 24, 1998

Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27W P Maksymowych, T Ikawa, A Yamaguchi, et al.

Cancer|December 15, 1983

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.

Arthritis and Rheumatism|November 11, 1999

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.

Journal of Medicinal Chemistry|September 1, 1995

Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activitiesS J Lee, Y Konishi, D T Yu, et al.

Arthritis and Rheumatism|June 12, 1999

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.

Clinical and Experimental Rheumatology|May 1, 1991

Epitope analysis of an HLA-B27-derived synthetic peptide: a possible approach to analyzing HLA class I antigensY P Zhao, B J Shi, H K Deng, et al.

Annals of Internal Medicine|April 15, 1993

Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.

Rheumatology (Oxford, England)|June 27, 2001

Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.

Arthritis and Rheumatism|November 18, 2000

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.

Pageof 20